Showing results (21-30 of 201) with videos related to
Sort By:
Pageof 21
Expert Review of Hematology|July 23, 2016
The role of proteasome inhibition in the treatment of malignant and non-malignant hematologic disordersRebecca Citrin, Jessica B Foster, David T TeacheyThe Journal of Allergy and Clinical Immunology. in Practice|March 29, 2023
Cytokine Storm Syndromes in Pediatric PatientsCaroline Diorio, David T Teachey, Scott W CannaNature Reviews. Clinical Oncology|November 15, 2024
Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocksCaroline Diorio, David T Teachey, Stephan A GruppExpert Review of Clinical Immunology|September 25, 2020
Chimeric antigen receptor T cell therapy for pediatric and young adult B cell acute lymphoblastic leukemiaRegina M Myers, Joseph Dolan, David T TeacheySeminars in Immunopathology|July 16, 2024
Riding the storm: managing cytokine-related toxicities in CAR-T cell therapyAndrew D Hughes, David T Teachey, Caroline DiorioBlood|October 2, 2024
Classification and risk stratification in T-lineage acute lymphoblastic leukemiaPetri Pölönen, Charles G Mullighan, David T TeacheyBlood Cancer Discovery|April 9, 2026
Genomic Insights into the Biology of T-lineage Acute Lymphoblastic LeukemiaPetri Pölönen, David T Teachey, Charles G MullighanImmunological Reviews|July 30, 2019
Cellular therapy: Immune-related complicationsJoseph H Oved, David M Barrett, David T TeacheyBlood|September 3, 2020
Optimizing therapy in the modern age: differences in length of maintenance therapy in acute lymphoblastic leukemiaDavid T Teachey, Stephen P Hunger, Mignon L LohBlood|February 16, 2024
How I treat ETP-ALL in childrenRyan J Summers, David T Teachey, Stephen P HungerPageof 21